Released on: September 16, 2008, 2:46 am

Press Release Author: Regenerative Medicine International

Industry: Healthcare

Press Release Summary: AdiStem, a leading provider of autologous, adipose-derived
adult stem cell products and procedures has appointed Regenerative Medicine
International to distribute their suite of stem cell therapies in Thailand.

Press Release Body: AdiStem’s stem cell therapies are unique in that they draw on
the individual’s own stem cells – not from a third party as the basis for the
therapy. The stem cell therapies address serious medical conditions such as type II
diabetes, breast reconstruction for cancer patients as well as cosmetic and plastic
surgery procedures.

"We are pleased that Adistem has chosen RMI to distribute their suite of stem cell
therapies in Thailand. We believe stem cell therapy represents a paradigm shift in
medical technology and we are excited to be at the forefront of this change in South
East Asia’s medical tourism hub “ said CEO Brian Dardzinski.

Thailand would be the third country in Asia to adopt AdiStem’s stem cell therapies,
behind the Philippines in 2006 and Korea in 2007. The Philippines and Korea have
undertaken approximately 200 successful treatments to date.

“RMI’s team has developed specialist knowledge in the field of stem cell marketing
and distribution over the last few years” said Dr. Bill Paspaliaris, Co-founder and
Chief Scientist with AdiStem “ which will allow us to expand our product
successfully throughout South East Asia. We are very excited about the potential
for the new technology.

Several doctors from Thailand’s top clinics and hospitals have already been trained
in Korea and RMI expects to license the technology to several hospital and clinics
over the next several months.

About Regenerative Medicine International
Regenerative Medicine International is dedicated to helping early stage stem cell
technology companies commercialize in the Asian market. With offices in Hong Kong
and Bangkok, Thailand, RMI and it's staff assist hospitals and doctors with
Regenerative Medicine Technologies aimed directly at improving the lives of
patients. RMI works with premier hospitals and clinics in the Asian region to assist
in marketing and distribution of cellular medicine. The company also provides a
patient portal, www.returninghope.com, to act as resource for people seeking stem
cell therapy anywhere in the world.

About AdiStem
Adistem is a biotechnology company which discovers, develops and provides to
licensed doctors autologous adult adipose-derived stem cell products that address
serious medical conditions and assist in particular cosmetic and plastic surgery
prodedures. AdiStem owns proprietary technologies which are licensed to major
hospitals and world class clinics.

For more information, please contact

Brian Dardzinski, CEO
bdardzinski@returninghope.com


Web Site: http://www.returninghope.com

Contact Details: 16th Floor, M Thai Tower, All Seasons Place
87 Wireless Road, Pathumwan, Bangkok 10330 Thailand